Cargando…
Delineating effects of angiopoietin-2 inhibition on vascular permeability and inflammation in models of retinal neovascularization and ischemia/reperfusion
INTRODUCTION: Clinical trials demonstrated that co-targeting angiopoietin-2 (Ang-2) and vascular endothelial growth factor (VEGF-A) with faricimab controls anatomic outcomes and maintains vision improvements, with strong durability, through 2 years in patients with neovascular age-related macular de...
Autores principales: | Canonica, Jérémie, Foxton, Richard, Garrido, Marina Garcia, Lin, Cheng-Mao, Uhles, Sabine, Shanmugam, Sumathi, Antonetti, David A., Abcouwer, Steven F., Westenskow, Peter D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291265/ https://www.ncbi.nlm.nih.gov/pubmed/37377777 http://dx.doi.org/10.3389/fncel.2023.1192464 |
Ejemplares similares
-
All-trans-Retinaldehyde Contributes to Retinal Vascular Permeability in Ischemia Reperfusion
por: Dreffs, Alyssa, et al.
Publicado: (2020) -
Minocycline prevents retinal inflammation and vascular permeability following ischemia-reperfusion injury
por: Abcouwer, Steven F, et al.
Publicado: (2013) -
Inflammatory resolution and vascular barrier restoration after retinal ischemia reperfusion injury
por: Abcouwer, Steven F., et al.
Publicado: (2021) -
Efficacy of simultaneous VEGF‐A/ANG‐2 neutralization in suppressing spontaneous choroidal neovascularization
por: Foxton, Richard H, et al.
Publicado: (2019) -
Protective Effect of a GLP-1 Analog on Ischemia-Reperfusion Induced Blood–Retinal Barrier Breakdown and Inflammation
por: Gonçalves, Andreia, et al.
Publicado: (2016)